The involvement of calcium-mediated signaling pathways in the mechanism of action of 1α,25-dihydroxyvitamin D 3 (1,25D) is currently demonstrated. In this study we found that 1,25D induces nongenomic effects mediated by membrane vitamin D receptor (VDRm) by modulating intermediate filament (IF) phosphorylation and calcium uptake through L-type voltage-dependent calcium channels (L-VDCC) in cerebral cortex of 10 day-old rats. Results showed that the mechanism of action of 1,25D involves intra-and extracellular calcium levels, as well as the modulation of chloride and potassium channels. The effects of L-VDCCs on membrane voltage occur over a broad potential range and could involve depolarizing or hyperpolarizing coupling modes, supporting a cross-talk among Ca 2+ uptake and potassium and chloride channels. Also, the Na (calcium, isotope of mass 45) uptake. Moreover, the 1,25D effect is dependent on the activation of the following protein kinases: cAMP-dependent protein kinase (PKA), Ca 2+ /calmodulin-dependent protein kinase (PKCaMII), phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase p38 (p38 MAPK ). The modulation of calcium entry into neural cells by the 1,25D we are highlighting, might take a role in the regulation of a plethora of intracellular processes. Considering that vitamin D deficiency can lead to brain illness, 1,25D may be a possible candidate to be used, at least as an adjuvant, in the pharmacological therapy of neuropathological conditions.
The involvement of calcium-mediated signaling pathways in the mechanism of action of 1α,25-dihydroxyvitamin D 3 (1,25D) is currently demonstrated. In this study we found that 1,25D induces nongenomic effects mediated by membrane vitamin D receptor (VDRm) by modulating intermediate filament (IF) phosphorylation and calcium uptake through L-type voltage-dependent calcium channels (L-VDCC) in cerebral cortex of 10 day-old rats. Results showed that the mechanism of action of 1,25D involves intra-and extracellular calcium levels, as well as the modulation of chloride and potassium channels. The effects of L-VDCCs on membrane voltage occur over a broad potential range and could involve depolarizing or hyperpolarizing coupling modes, supporting a cross-talk among Ca 2+ uptake and potassium and chloride channels. Also, the Na + /K + -ATPase inactivation by ouabain mimicked the 1,25D action on 45 
Ca
2+ uptake. The Na + /K + -ATPase inhibition observed herein might lead to intracellular Na + accumulation with subsequent L-VDCC opening and consequently increased 45 

2+
(calcium, isotope of mass 45) uptake. Moreover, the 1,25D effect is dependent on the activation of the following protein kinases: cAMP-dependent protein kinase (PKA), Ca
Introduction
1α,25-Dihydroxyvitamin D 3 (1,25D), the bioactive metabolite of vitamin D 3 , plays an essential role in the regulation of calcium and bone homeostasis [1] . In addition to these classic functions, vitamin D 3 has been shown to influence a variety of other systems such as mammary glands, reproductive organs, osteoblasts and the nervous system [2] [3] [4] [5] [6] [7] [8] [9] . The effects of 1,25D are mediated by its interaction with a nuclear vitamin D receptor (VDRn), a member of the nuclear receptor superfamily of ligand-activated transcription factors [10] . This interaction leads to either upregulation or downregulation of gene expression. On the other hand, it has been reported that 1,25D acts also through a plasma membrane-associated receptor (VDRm) which modulates a complex signaling system involving rapid formation of second messengers (Ca 2+ , cyclic AMP, inositol), activation of protein kinases (cAMP-dependent protein kinase-PKA; mitogenactivated protein kinase-MAPK) and the rapid opening of Ca 2+ and Cl − channels [6, 7, [11] [12] [13] [14] . The VDRm has been shown to be localized in caveolae-enriched plasma membranes [15, 16] . However, there is a current debate on the identity of the receptor(s) involved in the rapid nongenomic effect of vitamin D. There are two main candidates for the membrane receptor for 1,25D: the MARRS (membrane associated, rapid response, steroid-binding) protein and also new evidence indicates that the VDRn could also act as a membrane receptor [17] [18] [19] [20] . The VDR is widely distributed in the brain, including neurons and glial cells and is associated to many different functions [21, 22] . Previous studies have demonstrated that the VDR is expressed in both developing [23] and adult rat brain [24, 25] , as well as in human brain [26, 27] . Regarding its functions, several studies have postulated that 1,25D modulates the activity of brain genes and enzymes of neurotransmitter metabolism, and is also involved in neuroprotection and brain development [3, 4, 28, 29] .
The cytoskeleton of the neural cells comprises a protein network composed by microtubules, microfilaments and intermediate filaments (IFs). Neurofilaments are heteropolymers that are expressed almost exclusively in neurons. They are composed of three different polypeptides commonly referred to as heavy (NFH), medium (NFM), and light (NFL) NF subunits [30] . Under normal conditions, the three NF subunits coassemble stoichiometrically into filamentous structures playing a role in maintaining axonal caliber [31] and axonal transport [32] . Vimentin and glial fibrillary acidic protein (GFAP) are the IFs found in astrocytes [30, 33] . GFAP is the IF of mature astrocytes [34] , while vimentin is the IF of mesenchymal origin. The phosphorylation of IF proteins is a dynamic process controlling their physiological role in response to extracellular signals. The importance of GFAP and NF subunits on neural function is evident from the fact that perturbation of their structure accounts for several genetically determined protein misfolding/aggregation diseases [35] . Also, perikaryal accumulations/ aggregations of NF proteins have been correlated with aberrantly phosphorylated NF in several neurodegenerative diseases, such as Alzheimer's disease, motor neuron diseases, and Parkinson's disease [36] [37] [38] . Also, the misregulation of the IF-associated phosphorylation system is assumed to have an important role in neurodegeneration.
Our research group has previously demonstrated that the phosphorylating system associated with the IF proteins is responsive to hormonal signals [5, [39] [40] [41] [42] [43] . These actions can be initiated by the activation of L-type voltage-dependent Ca 2+ channels (L-VDCC) and the signal is transduced downstream of Ca 2+ uploading through different kinase pathways, regulating the dynamics of the cytoskeleton [5, 41] . The phosphorylating system associated with the IF proteins has been previously shown to be targeted by 1,25D in the male reproductive system. However, the intracellular pathways involved in 1,25D actions targeting the neural cytoskeleton and the involvement of Ca 2+ in such actions remain to be identified.
Calcium signaling plays a central role in neuronal cell development. Accordingly, the VDCCs are highly expressed during development and their functions are critical for developing neurons [44] , as well as for synaptogenesis [45, 46] . One of the ways in which Ca 2+ channels influence neuronal activities is via signaling pathways that control gene expression and that involve transcription factors such as cyclic AMP response element-binding protein (CREB) [47, 48] . Also, the critical role of VDCCs regulating the secretion of neurotransmitters must be considered [49] .
It has been shown that the steroid hormone 1,25D has modulatory effects on cytoskeleton, neurotransmission, antioxidant system, as well as Ca 2+ and Cl − channel activities in a variety of cell types [5, [50] [51] [52] .
Taking into account these findings in the present study we explore the mechanisms involved in the rapid effect of 1,25D on IF phosphorylation and on 45 Ca 2+ uptake in slices of cerebral cortex from immature male rats in an attempt to better understand the relevance of this hormone to the brain function.
Materials and methods
Chemicals
1α,25-Dihydroxyvitamin D 3 (1,25D), nifedipine, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis (acetoxymethyl
PD 98059, ouabain, theophylline, dibutyryl cAMP (di-BucAMP), 9-anthracene carboxylic acid (9-AC), flunarizine, dantrolene sodium salt, 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS), tolbutamide, apamine, N- [2- 
Animals
Wistar rats were bred in an animal house and maintained in an air-conditioned room (about 21°C) with controlled lighting (12 h/12 h light/dark cycle). The suckling rats were kept with their mothers until euthanasia. Pelleted food (Nuvital, Nuvilab CR1, Curitiba, PR, Brazil) and tap water were available ad libitum. All animals' procedures were carried out in accordance with ethical recommendations of the Brazilian Veterinary Medicine Council and the Brazilian College of Animal Experimentation (Protocol CEUA/PP00179).
Preparation of cerebral cortex slices
Ten day-old male rats were killed by decapitation, and the cerebral cortex was dissected onto Petri dishes placed on ice and cut into 400 μm thick slices with a Mcllwain chopper. 
2.4.
P labeling
Slices of cerebral cortex from 10 day-old male rats were initially preincubated at 30°C for 20 min in a Krebs-HEPES medium containing 124 mM NaCl, 4 mM KCl, 1.2 mM MgSO 4 , 25 mM Na-HEPES (pH 7.4), 12 mM glucose, 1 mM CaCl 2 , and the following protease inhibitors: 1 mM benzamidine, 0.1 μM leupeptin, 0.7 μM antipain, 0.7 μM pepstatin and 0.7 μM chymostatin in the presence or absence of 10 μM H89 [40, 43, [53] [54] [55] , 30 μM PD 98059 [43] ; 10 μM nifedipine [43, 56, 57] , 50 μM BAPTA-AM [43, 58, 59] , 0.35 mM cycloheximide [39, 43] or 1 μM Ro 31-8220 [6, 60] , when indicated. After preincubation, the medium was changed and incubation was carried out at 30°C with 100 μl of the basic medium containing 80 μCi of radioactive orthophosphate assures the maximal production of labeled ATP. This experimental approach has been developed by our research group [61] and has been largely used in quantitative studies of the in vitro 32 P incorporation into cytoskeletal proteins in different tissues and experimental models [5, [39] [40] [41] [42] [43] [62] [63] [64] . The labeling reaction was normally allowed to proceed for 30 min at 30°C and stopped with 1 ml of ice-cold stop buffer (150 mM NaF, 5 mM, EDTA, 5 mM EGTA, 50 mM Tris-HCl, pH 6.5), and the protease inhibitors described above. Slices were then washed twice with stop buffer to remove excess radioactivity and maintained on ice at 4°C.
Preparation of the high salt-Triton insoluble cytoskeletal fraction
After the labeling reaction, slices were homogenized in 400 μl of ice-cold high salt buffer containing 5 mM KH 2 PO 4 , (pH 7.1), 600 mM KCl, 10 mM MgCl 2 , 2 mM EGTA, 1 mM EDTA, 1% Triton X-100 and the protease inhibitors described above. The homogenate was centrifuged at 15,800 ×g for 10 min at 4°C, in an Eppendorf centrifuge, the supernatant discarded and the pellet homogenized with the same volume of the high salt medium. The resuspended homogenate was centrifuged as described and the supernatant was discarded. The Triton-insoluble IF-enriched pellet, containing NF subunits, vimentin and GFAP, was dissolved in 1% SDS and protein concentration was determined.
Polyacrylamide gel electrophoresis (SDS-PAGE)
The cytoskeletal fraction was prepared as described above. Equal protein concentrations were loaded onto 10% polyacrylamide gels and analyzed by SDS-PAGE according to the discontinuous system of Laemmli [65] . After drying, the gels were exposed to X-ray films (X-Omat XK1) at − 70°C with intensifying screens and finally the autoradiograph was obtained.
Western blot analysis
In some experiments tissue slices were treated with 1,25D during 5, 10, 15 and/or 30 min, then total tissue extracts were processed to Western blot analysis. The nitrocellulose membranes were washed for 10 min in Tris-buffered saline (TBS; 0.5 M NaCl, 20 mM Trizma, pH 7.5), followed by 2 h incubation in blocking solution (TBS plus 5% defatted dried milk). After incubation, the blot was washed twice for 5 min with TBS plus 0.05% Tween-20 (T-TBS), and then incubated overnight at 4°C in blocking solution containing the following monoclonal antibodies designated to study the MAPK cascade: anti-ERK1/2, anti-phospho ERK1/2, anti p38 MAPK and anti-phospho p38 MAPK antibodies (diluted 1:2000). The blot was then washed twice for 5 min with T-TBS and incubated for 2 h in TBS containing peroxidase conjugated anti-rabbit IgG 1:1000. The blot was washed twice again for 5 min with T-TBS and twice for 5 min with TBS. The blot was then developed using Immobilon™ Western chemiluminescent HRP substrate.
Quantitation of Western blot and 32 P incorporation into IF proteins
The radioactivity incorporated into cytoskeletal proteins as well as the immunoblots were quantified by scanning the films with a Hewlett-Packard Scanjet 6100C scanner and by determining optical densities for the band corresponding to each protein. Control values were then normalized to 100% and the percentage changes in the test samples were calculated. Protein loading was controlled by Coomassie blue staining the gels. , and 10 −7 M) for 5 min. In some experiments channel blockers or kinase inhibitors were added during the last 20 min before hormone addition and maintained during all the incubation period (see figures). The following drugs were used: nifedipine (10 μM), flunarizine [70] . After washing, tissue slices were homogenized with 0.5 M NaOH solution, 100 μl aliquots were placed in scintillation fluid and counted in a LKB rack beta liquid scintillation spectrometer (model LS 6500; Multi-Purpose Scintillation CounterBeckman Coulter, Boston, USA) [52, 66, 69] , and 5 μl aliquots were used for protein quantification as described by Lowry and colleagues [71] .
VDR and caveolin-1 immunohistochemistry
Control animals were anesthetized with xylazine (0.1 ml/100 g body weight, i.m.) and ketamine (0.1 ml/100 g body weight, i.m.) and perfused with phosphate buffered saline (PBS) with heparin (50 ml in the 15-day-old rats) followed by 4% paraformaldehyde diluted in 0.1 M phosphate buffer (pH 7.4) at 4°C of the same flow rate and total amount. The perfusion rate was approximately 100 ml. After perfusion, the brain was extracted from the skull, weighed, and placed in the same fixing solution for 72 h. After fixation, the brain was washed for 1 h in running water, dehydrated in increasing concentrations of ethanol (70%, 80%, 90%, 95% and absolute ethanol) and cleared with xylol. Brains were then embedded in paraplastic resin (Histosec; Merk). Coronal serial sections (3 μm thickness) were obtained with a microtome and serially collected on glued slides. Brain slides were deparaffinized in toluene, rehydrated in ethanol and rinsed in tap water. After this step, sections were placed in 0.1 M sodium citrate and citric acid buffer, heated for 20 min in a 350 W microwave oven, allowed to cool for 60 min, and rinsed in tap water and in PBS three times. Sections then were contoured with Dakopen and nonspecific binding sites were blocked with 3% PBS-BSA for 60 min at room temperature. Thereafter sections were incubated overnight with rabbit anti-VDR polyclonal antibody, mouse anti-caveolin-1 (1:500 in 3% PBS-BSA) and/or mouse anti-NeuN (1:1000 in 3% PBS-BSA) at 4°C. After thorough rinsing, all sections were incubated with goat anti-mouse IgG conjugated to Alexa Fluor® 430 (1:500) and/or goat anti-rabbit IgG conjugated Alexa Fluor® 594 (1:500) for 45 min at room temperature and washed with PBS. Nucleus were stained with DAPI (0.25 μg/ml) and covered with ProLong® Gold Antifade Reagent and coverslips. Negative controls were performed without primary antibody. Images were captured with a fluorescence microscope (Olympus, BX-41) equipped with a digital camera (3.3 Mpixel QCOLOR3C, Qimaging™) and image acquisition software (Qcapture Pro 5.1, Qimaging™).
Statistical analysis
The results are means ± S.E.M. When multiple comparisons were performed, evaluation was done using one-way ANOVA followed by a Bonferroni multiple comparison test. Differences were considered to be significant when p b 0.05.
Results
Glial and neuronal IF proteins as a target of membrane-initiated actions of 1,25D
Slices of cerebral cortex were exposed to different concentrations of 1,25D and the in vitro phosphorylation of IF-enriched cytoskeletal fraction was investigated. Results showed that 1,25D exposure for 30 min increased the IF phosphorylation at doses ranging from 10 − 10 to 10 − 7 M (Fig. 1) . The following experiments were carried out by using 10 − 10 M 1,25D. The hormone-induced IF phosphorylation was totally independent on protein synthesis, as attested by using 0.35 mM cycloheximide, a potent inhibitor of protein synthesis (Fig. 2) , therefore, supporting a nongenomic action of 1,25D directed to the IF-associated phosphorylating system.
Involvement of PKA, PKC, PKCaMII and MAPK on 1,25D-induced IF phosphorylation
The contribution of different protein kinases known to target the IF proteins [5] was investigated. Interestingly, the effect of 1,25D (100 pM) was unaffected by the presence of either protein kinase C (PKC) or MAP kinase kinase (MEK) inhibitors (Ro 31-8220 and PD 98059, respectively) (Fig. 3A) . However, 10 μM H89 (PKA inhibitor) or 10 μM KN93 (PKCaMII inhibitor) totally prevented the 1,25D-induced hyperphosphorylation (Fig. 3B) . Altogether, these findings demonstrate a role for PKA and PKCaMII in the mechanism of the hormonal action on the homeostasis of the phosphorylating system targeting the cytoskeleton.
Involvement of calcium on 1,25D-induced IF phosphorylation
The contribution of calcium signaling to the 1,25D-triggered events targeting the cytoskeleton was verified by using 10 μM nifedipine (L-VDCC blocker) and 50 μM BAPTA-AM (cell permeable calcium quelator). Results showed that co-incubation of 1,25D with each one of these drugs was able to prevent the hormone-stimulated IFphosphorylation, evidencing a calcium-dependent mechanism (Fig. 4) . In order to clarify these findings, the mechanisms involved in 1,25D-mediated Ca 2+ entrance were investigated. and flunarizine, L-and T-VDCC blockers, respectively, were used. Results showed that nifedipine (10 μM) prevented the 1,25D action while flunarizine (1 μM) did not alter the hormone effect, indicating the participation of L-VDCC in the mechanism of hormone action (Fig. 6A) . Once the participation of L-VDCC on 45 Ca 2+ uptake in cerebral cortex was established, we also sought to determine if the intracellular Ca 2+ levels could play a role in regulating the VDCC activity by using BAPTA-AM to chelate the intracellular Ca
2+
. Therefore we found that in the presence of BAPTA-AM the stimulatory effect of 1,25D on the L-VDCC was abrogated. In addition, the use of dantrolene (50 μM) allowed us to set the implication of ryanodin receptors in the mechanism of action of 1,25D (Fig. 6B) . The VDCCs can open in response to changes on resting membrane potential; therefore, in order to investigate if K + efflux or Cl − influx could lead to 45 Ca 2+ uptake through VDCCs we used specific blockers for ATP-dependent K + channels (tolbutamide), as well as for calcium-dependent Cl − channels (9-AC). Results showed that both tolbutamide (100 μM) and 9-AC (1 μM) prevented the hormone stimulated 45 Ca 2+ uptake (Fig. 6C) . These data suggest the involvement of K + and Cl − channels in the mechanism of action of 1,25D in cerebral cortex. uptake. In addition, we did not observe an additional stimulatory effect when the tissue was co-incubated with the hormone, suggesting that cAMP on its own participates in the mechanism of action of 1,25D on 45 Ca 2+ uptake. Also, the effect of 1,25D was sustained in the presence of a phosphodiesterase inhibitor (50 μM theophylline) (Fig. 8A) The participation of other protein kinases such as PKCaMII, PI3K, PKC, and MAPK signaling pathways in 1,25D actions was investigated by using the specific inhibitors: (10 μM) KN93, (10 μM) LY294002, (20 μM) Ro 31-8220, (10 μM) PD 98059 and (10 μM) SB239063, respectively. The outcomes showed that KN93, LY 294002, as well as . In the last 20 min preincubation 10 μM nifedipine (L-VDCC blocker) or 1 μM flunarizine (T-VDCC blocker) (A); 50 μM BAPTA-AM (intracellular calcium chelator) or 50 μM dantrolene (ryanodine calcium channel blocker) (B); 100 μM tolbutamide (ATP-dependent potassium channel blocker) or 1 μM 9-AC (calcium-dependent chloride channel blocker) (C), was added to the incubation medium. After that, the slices were treated with or without 1,25D for 5 min (incubation). Data are reported as means±SEM of 8 animals in each group and expressed as % of control. Statistically significant differences from controls, as determined by one-way ANOVA followed by a Bonferroni multiple comparison test are indicated: ⁎⁎ Pb 0.01 compared with control group. 45 Ca 2+ uptake in cerebral cortex of rats.
Slices of cerebral cortex were pre-incubated for 60 min in the presence of 0.1 μCi/ml of 45 Ca 2+ . In the last 20 min preincubation 1 μM ouabain (Na + /K + -ATPase inhibitor) was added to the incubation medium. After that, the slices were treated with or without 1,25D (100 pM) for 5 min (incubation). Data are reported as means ± SEM of 8 animals in each group and expressed as % of control. Statistically significant differences from controls, as determined by one-way ANOVA followed by a Bonferroni multiple comparison test are indicated: ⁎ P b 0.05 and ⁎⁎ P b 0.01 compared with control group. SB239063 totally prevented the stimulatory effect of the hormone while Ro 31-8220 and PD98059 did not change the 1,25D stimulation on 45 Ca 2+ uptake (Fig. 8B) 
MAPK modulation by 1,25D
To attest the modulation of MAPKs by 1,25D, we investigated the effect of different times (5, 10, 15 and 30 min) of exposure to the hormone on the activation profile of the enzymes, measuring the total and phosphorylated levels of ERK1/2 and p38 MAPK in cerebral cortex from immature rats. Results showed that the total levels of ERK1/2 and p38 MAPK were unaltered from 1 to 30 min (Fig. 9A and C) , while the phospho-ERK1/2 and phospho-p38 MAPK levels significantly increased the first 5 min incubation returning to control levels at 30 min exposure to the hormone (Fig. 9B and D) .
3.10. VDR/caveolin-1 and VDR/NeuN immunolocalization in cerebral cortex from young rats Fig. 10 shows the VDR and caveolin-1 immunolocalization in the cerebral cortex cells from young rats. The nuclear staining with DAPI (blue) was demonstrated in Fig. 10A . The analysis revealed a strong cellular peripheral VDR immunoreactivity (red), but also a weak staining is shown in the nucleus of neural cells from cerebral cortex (Fig. 10B ). In addition, immunoreactive caveolin-1 (green) was largely distributed in the cytosol and cell membrane but was largely absent in the nucleus (Fig. 10C) . The colocalization of VDR and caveolin-1 is depicted in Fig. 10D . Apparently, VDR and caveolin-1 are immunolocalized in neurons (distinct nucleolus within an ovoid nucleus and elongated perikarya) and are not present in glial cells (characterized by their much smaller size when compared with the neighboring neurons). Fig. 11 shows the VDR and NeuN immunolocalization in the cerebral cortex cells from 15-day-old rats. Results demonstrated the NeuN immunoreactivity (green; Fig. 11A ) and VDR immunoreactivity (red; Fig. 11B ). The nuclear staining with DAPI (blue) was shown in Fig. 11C . The outcomes clearly demonstrated that VDR and NeuN are co-localized, indicating the expression of the VDR in neurons.
Discussion
In this study we found that 1,25D induced nongenomic effects in cerebral cortex of immature rats by modulating Ca 2+ -mediated signal transduction, the homeostasis of the cytoskeleton, and neurochemical parameters. Results showed that the mechanism of hormonal action involves the participation of protein kinases, intra-and extracellular Ca 2+ , as well as the modulation of Cl − and K + channels.
The evidence that vitamin D plays critical roles in brain physiology is becoming recognized from findings linking vitamin D deficiency and the development of neuropsychiatric disorders [72, 73] . Vitamin D and its metabolites were found in human cerebrospinal fluid several years ago [74] , however, the evidence that this hormone plays important roles in brain was only provided after demonstration of the presence of the VDR in the central nervous system [75] [76] [77] and the involvement of 1,25D in brain function and development [73, [78] [79] [80] . Nonetheless, several questions are still open concerning the 1,25D mechanism of action in brain. Interestingly, a strong VDR immunostaining in close proximity to the neuronal cell membrane is clearly visible, which is colocalized with the plasma membrane protein caveolin-1. It is classically described that 1,25D regulates gene transcription through modulation of VDRn [1] . Moreover, initiation of rapid cellular responses is attributed to a putative plasma membrane-associated receptor (VDRm) which is present in a caveolae-enriched membrane fraction [12, 16] . In this context MARRS binding protein [17, 18] and the classical VDR [15] have been suggested as possible candidates for the VDRm. Taking into account these findings, our data support the conclusion that the classical VDR, which is normally found in the nucleus, is also a neuronal plasma membrane-associated receptor, as demonstrated by the colocalization of VDR and caveolin-1 in cerebral cortex of immature rats. However, we could not exclude the participation of MARRS protein in the mechanism of action of 1,25D in cerebral cortex. Further experiments will be necessary to clarify this point.
Considering the relevance of the cytoskeleton to the physiology of neural cells, we were interested to assess the molecular mechanisms underlying the actions of 1,25D on the phosphorylation of GFAP, vimentin and neurofilament subunits in the cerebral cortex of immature rats. In this context, we have previously demonstrated the vimentin phosphorylation and polymerization/aggregation as a target of 1,25D in immature rat testis [5] . Therefore, in the present report we have demonstrated that 1,25D is upstream of complex membraneinitiated signaling pathways leading to phosphorylation of the IF proteins from astrocytes (GFAP and vimentin) and neurons (NF-L and NF-M). However, although the immunohistochemical analyses indicated that VDR is only expressed in neurons, 1,25D induced the phosphorylation of GFAP and vimentin, which are proteins expressed in an astrocyte. The mechanisms underlying such effects probably involve complex signaling events and interactions between cells. In this context, the neurons may provide additional opportunities for cross-talk between them and the neighboring cells, such as the astrocytes. Also, other proteins, such as MARRS, might be participating in the mechanism of action of 1,25D in glial cells, as demonstrated in other tissues [19, 20] .
Considering the relevance of Ca 2+ overload on the modulation of the phosphorylating system associated with the cytoskeleton [5, 42, 81, 82] [5, 6, 9, 52, 85] . Also, our results provide evidence that 45 
Ca
2+ uptake induced by 1,25D is associated with the modulation of L-VDCC but is unaffected by T-VDCC. These findings highlight the critical role of L-VDCC as a mediator of the actions of 1,25D targeting phosphorylation sites on IF proteins, although we cannot exclude the participation of other VDCCs in the modulation of intracellular Ca 2+ levels.
The Ca 2+ influx via VDCCs frequently occurs after plasma membrane depolarization. These mechanisms then set off a cascade of events including activation of protein kinases, which phosphorylate head domain sites on GFAP and NFL [64] . To clarify the involvement of ionic fluxes in the mechanism of action of 1,25D, we investigated the participation of Cl − and K + channels and also the Na 45 
2+ uptake in cerebral cortex slices. It is important to emphasize that coincubation with ouabain and 1,25D did not result in an additive effect, suggesting that they might have a similar mechanism take is triggered by the influx of this ion through L-VDCC and that PKA plays an important role in mediating this effect which are in line with previous studies [6, 9, 85] and with the evidence that PKC and PKA play central roles in signal transduction in many cell types [66, 88, 89] . Accordingly, it has been demonstrated that L-VDCC phosphorylation by PKA in skeletal muscle resulted in an activation and opening of the channels [90] [91] [92] . Moreover, Vela et al. [93] showed that PKA and PKC activation leads to depolarization- [94] . Also, the phosphorylation of the β subunit of L-VDCC by PKB/Akt, a key effector of the PI3K signaling pathway, was demonstrated to modulate the gating of these channels [95, 96] , further supporting the involvement of PI3K on Ca 2+ influx induced by 1,25D as observed by us in immature rat brain. The early stages of brain development are recognized as the periods of intense synaptogenesis associated with enhanced neuronal activity and augmented synaptic plasticity [97] . Interestingly, the PI3K activation was associated with induction of functional synaptogenesis in the hippocampus [98] . Taken together, this evidence supports the idea that 1,25D also might induce synapse formation through PI3K-mediated mechanisms in immature rat brain.
It is now clear that there are interfaces between 1,25D nongenomic and genomic actions [15, 99] . The involvement of p38 MAPK and PI3K in the mechanism of action of 1,25D suggests that probably a nongenomic-initiated action might lead to late activation of genomic pathways, considering that both of these kinases can activate transcriptional factors and modulate gene transcription [15] . Moreover, the modulation of MAPK signaling pathways may transduce the 1,25D signal into complex cellular events, such as aromatase expression [8] phosphorylation demonstrated in this study is in agreement with previous reports showing that this kinase induces L-VDCC to enter a gating mode. The authors showed that PKCaM-mediated phosphorylation is an essential signaling event triggering L-VDCC facilitation [100] . The PKCaMII is one of the most prominent protein kinases present in the brain. The activity of PKCaMII regulates important neuronal functions, such as neurotransmitter synthesis and release, modulation of ion channel activity, cellular transport, cytoskeleton phosphorylation, cell morphology and synaptic plasticity. Also, it is involved in learning and memory, as well as in modulation of gene expression [40, 43, 100, 101] . It has also been reported that PKCaMII can phosphorylate and activate the glutamatergic receptor AMPA resulting in an increase of Ca 2+ entry into postsynaptic neurons and that this event could be related to long-term potentiation [101] , and consequently could be involved with learning and memory. The involvement of different protein kinases in the mechanism of action of 1,25D in the brain provides an evidence of the hormonal action and intracellular targets of the hormone during brain development. In summary, the present study strongly suggests that 1,25D induces IF phosphorylation and Ca 2+ influx by modulating L-VDCC opening through different kinase activities, as well as by regulating ionic fluxes in cerebral cortex of young rats. An overview of the proposed mechanism of action for 1,25D in the cerebral cortex of young rats is depicted in Fig. 12 . The modulation of Ca 2+ entry into neural cells by the hormone might participate in the regulation of a plethora of intracellular processes, such as IF phosphorylation, modulation of neurotransmission, enzymatic activity, protein synthesis and cell proliferation, as well as synapse formation, reinforcing 1,25D as a neuroactive substance that could participate in brain pathology and physiology. Considering that vitamin D deficiency can lead to several types of brain illness, it may be a possible candidate to be used, at least as an adjuvant, in the pharmacological therapy of neuropsychiatric conditions.
